US Patent Issued to THOMAS HELLEDAYS STIFTELSE FOR MEDICINSK FORSKNING on July 15 for "2,6-diamino-3,4-dihydropyrimidin-4-one derivatives and use thereof in therapy" (Swedish Inventors)

Posted On: 2025-07-16

ALEXANDRIA, Va., July 16 -- United States Patent no. 12,357,634, issued on July 15, was assigned to THOMAS HELLEDAYS STIFTELSE FOR MEDICINSK FORSKNING (Stockholm).

"2,6-diamino-3,4-dihydropyrimidin-4-one derivatives and use thereof in therapy" was invented by Christoffer Bengtsson (Bromma, Sweden), Sanjay Borhade (Lund, Sweden), Martin Haraldsson (Taby, Sweden), Thomas Helleday (Stocksund, Sweden), Martin Henriksson (Bromma, Sweden), Evert Homan (Sollentuna, Sweden), Cynthia Paulin (Bandhagen, Sweden), Lars Sandberg (Enskede, Sweden), Martin Scobie (Uppsala, Sweden), Pal Stenmark (Jarfalla, Sweden) and Karl Vallin (Stockholm).

According to the abstract* released by the U.S. Patent & Trademark Office: "A compound of formula Ior a pharmaceu...

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

US Patent Issued to THOMAS HELLEDAYS STIFTELSE FOR MEDICINSK FORSKNING on July 15 for "2,6-diamino-3,4-dihydropyrimidin-4-one derivatives and use thereof in therapy" (Swedish Inventors)